| Pulmonary Fibrosis Foundation Community Registry (NCT05382572) | Pulmonary Fibrosis Foundation | 2022-07-11 |
| 68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19 (NCT05981885) | University Medical Center Groningen | 2022-06-09 |
| A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease (NCT05331300) | Lassen Therapeutics 1 PTY LTD | 2022-06-06 |
| Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF (NCT05330312) | Vicore Pharma AB | 2022-04-17 |
| Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital (NCT04979884) | Alexandria University | 2022-01-03 |
| 99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis (NCT05859763) | Peking Union Medical College Hospital | 2021-12-12 |
| Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 (NCT05180162) | Thomas Hope | 2021-12-09 |
| Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT (NCT05121779) | Peking Union Medical College Hospital | 2021-11-18 |
| FAPI PET for Lung Fibrosis (NCT05365802) | University of California, Los Angeles | 2021-11-16 |
| Dyspnea and Idiopathic Pulmonary Fibrosis (NCT04864990) | University Hospital, Lille | 2021-10-22 |
| Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs (NCT04930289) | Paragonix Technologies | 2021-10-15 |
| Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases (NCT04119115) | Corewell Health East | 2021-09-30 |
| Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland (NCT06702228) | Royal College of Surgeons, Ireland | 2021-09-28 |
| The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis (NCT04638517) | The University of Queensland | 2021-09-07 |
| Interstitial Lung Disease Research Unit Biobank (NCT05392881) | University of Kansas Medical Center | 2021-08-09 |
| COVID-19 Pathophysiology of Long Term Implications (NCT04813575) | King Faisal Specialist Hospital & Research Center | 2021-08-01 |
| Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis (NCT04948203) | University of Chicago | 2021-07-09 |
| Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions (NCT04987606) | Imperial College London | 2021-07-01 |
| The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. (NCT06160440) | Guangzhou JOYO Pharma Co., Ltd | 2021-06-03 |
| The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 (NCT04805086) | Guy's and St Thomas' NHS Foundation Trust | 2021-03-08 |
| Fibrosing ILD Biomarkers That Rule Acceleration (NCT05635032) | Universidade do Porto | 2021-03-01 |
| Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression (NCT04136223) | Hospital do Coracao | 2021-03-01 |
| Advancing Prevention of Pulmonary Fibrosis (NCT04564183) | University of Colorado, Denver | 2021-01-22 |
| Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest (NCT04170062) | Johns Hopkins University | 2020-12-15 |
| A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension (NCT03267108) | Bellerophon Pulse Technologies | 2020-12-14 |
| RENOVATE Fibrosis:HFNC Versus NIPPV in Acute Respiratory Failure in Patients With Pulmonary Fibrosis (NCT04253405) | Hospital do Coracao | 2020-12-10 |
| Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge (NCT04537130) | Instituto Oncológico Dr Rosell | 2020-12-01 |
| The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 (NCT04619680) | Icahn School of Medicine at Mount Sinai | 2020-11-18 |
| BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients (NCT04482595) | Humanetics Corporation | 2020-11-11 |
| Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders (NCT02748798) | Thunder Bay Regional Health Research Institute | 2020-11-10 |
| Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD (NCT04680832) | Erasmus Medical Center | 2020-11-01 |
| A Non-pharmacological Cough Control Therapy (NCT04767074) | West Park Healthcare Centre | 2020-09-01 |
| Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients (NCT04517162) | Janette Furuzawa Carballeda | 2020-08-19 |
| A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis (NCT04308681) | Bristol-Myers Squibb | 2020-07-29 |
| LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION (NCT04409275) | Fundación para la Investigación del Hospital Clínico de Valencia | 2020-05-21 |
| SVF for Treating Pulmonary Fibrosis Post COVID-19 (NCT06304623) | Michael H Carstens | 2020-05-05 |
| An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology (NCT04304898) | Erasmus Medical Center | 2020-05-01 |
| Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) (NCT04416100) | Medical University Innsbruck | 2020-04-29 |
| Pulmonary Fibrosis During Severe COVID-19 Pneumonia (NCT04987528) | Hôpital Européen Marseille | 2020-03-11 |
| Pulmonary Fibrosis After Severe COVID-19 Pneumonia (NCT06423560) | IRCCS San Raffaele | 2020-03-01 |
| A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis (NCT03727451) | Bellerophon | 2019-01-30 |
| Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients (NCT03535545) | Massachusetts General Hospital | 2018-08-01 |
| Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (NCT03567785) | KU Leuven | 2018-07-17 |
| Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease (NCT03455686) | McMaster University | 2018-04-19 |
| Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies (NCT03385668) | Assistance Publique - Hôpitaux de Paris | 2018-01-31 |
| A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis (NCT05747508) | Bellerophon | 2017-12-29 |
| Accuracy of Spircare Device as Compared to the Conventional Plethysmograph (NCT03056066) | Spircare Ltd. | 2017-07-31 |
| Spanish Version of the KBILD Questionnaire (NCT03103178) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2017-01-01 |
| Diagnostic Value of KL-6 in ILD (NCT03103191) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2016-06-01 |
| Computerized Lung Sound Analysis (NCT02771184) | Smolle-Juettner Freyja, Prof MD | 2016-04-01 |
| Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis (NCT02603068) | United Therapeutics | 2016-02-01 |
| Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis (NCT02510937) | Celgene | 2015-08-05 |
| Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment (NCT02496182) | Grupo Medifarma, S. A. de C. V. | 2015-07-01 |
| Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome (NCT02439528) | Hospices Civils de Lyon | 2015-03-25 |
| Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease (NCT02055222) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-10-14 |
| Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis (NCT03542318) | University of Malta | 2014-03-01 |
| Supplemental Oxygen in Pulmonary Fibrosis (NCT01961362) | National Jewish Health | 2013-10-01 |
| Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability (NCT01615484) | University of North Carolina, Chapel Hill | 2013-09-01 |
| Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab (NCT01917877) | Qingdao Central Hospital | 2013-08-01 |
| Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation (NCT01916577) | University of Colorado, Denver | 2013-08-01 |
| Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases (NCT01825538) | Jennifer McCallister MD | 2013-02-01 |
| The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis (NCT07031362) | Izmir Katip Celebi University | 2013-01-01 |
| Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis (NCT02594059) | Hopital Foch | 2012-12-19 |
| Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis (NCT02668029) | University of Siena | 2012-04-01 |
| Pulmonary Fibrosis and Telomerase Mutation Study (NCT01501578) | Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | 2011-12-01 |
| Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174) (NCT01417156) | Boehringer Ingelheim | 2011-09-01 |
| Clinical and Pathophysiological Investigations Into Erdheim Chester Disease (NCT01417520) | National Human Genome Research Institute (NHGRI) | 2011-08-01 |
| Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II (NCT01335477) | Boehringer Ingelheim | 2011-05-01 |
| Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients (NCT01335464) | Boehringer Ingelheim | 2011-04-01 |
| A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) (NCT01203943) | Celgene | 2011-01-01 |
| Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability (NCT01241942) | University of North Carolina, Chapel Hill | 2010-12-01 |
| Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study (NCT01271842) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-10-01 |
| Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF) (NCT01170065) | Boehringer Ingelheim | 2010-06-25 |
| Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology (NCT01687946) | Medical University of Vienna | 2010-06-01 |
| Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema (NCT01121367) | Beijing Chao Yang Hospital | 2010-05-01 |
| Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung Disease (NCT01653730) | Ottawa Hospital Research Institute | 2010-02-01 |
| Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology (NCT03462524) | St. James's Hospital, Ireland | 2010-01-01 |
| Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF (NCT00650091) | Duke University | 2009-10-01 |
| Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis (NCT00981747) | Alicia Gerke | 2009-09-01 |
| A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT00786201) | Centocor, Inc. | 2008-12-01 |
| Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients (NCT00896155) | Tata Memorial Hospital | 2008-12-01 |
| Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis (NCT00690885) | Ainos, Inc. (f/k/a Amarillo Biosciences Inc. | 2008-06-01 |
| Dyspnea in Patients With Pulmonary Fibrosis (NCT00611182) | University of California, San Francisco | 2008-01-01 |
| Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis (NCT00517933) | Duke University | 2007-08-01 |
| Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis (NCT00514683) | Boehringer Ingelheim | 2007-08-01 |
| The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis (NCT00504621) | Maastricht University Medical Center | 2007-08-01 |
| Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome (NCT00467831) | National Human Genome Research Institute (NHGRI) | 2007-04-01 |
| Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis (NCT00439543) | Interstitial Lung Disease Study Group, Korea | 2007-03-01 |
| Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease (NCT00911794) | Winthrop University Hospital | 2007-01-01 |
| A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis (NCT00563212) | NYU Langone Health | 2007-01-01 |
| Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases (NCT00366509) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-09-18 |
| Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients (NCT00455767) | Debiopharm International SA | 2006-07-01 |
| Explanted Lung Tissues With Pulmonary Fibrosis (NCT00515567) | University of Chicago | 2006-02-01 |
| Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome (NCT00001596) | William Gahl, M.D. | 2005-09-01 |
| Using Health-related Quality of Life (HRQL) in Routine Clinical Care (NCT00457301) | University of Alberta | 2005-07-01 |
| Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis (NCT00109681) | Actelion | 2005-04-01 |
| Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension (NCT00352482) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-11-01 |
| Analysis of Specimens From Individuals With Pulmonary Fibrosis (NCT00084305) | National Human Genome Research Institute (NHGRI) | 2004-06-09 |
| The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) (NCT00075998) | InterMune | 2003-12-01 |
| Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (NCT00080223) | Genentech, Inc. | 2003-08-31 |